Cargando…

Adenovirus-vectored SARS-CoV-2 vaccine expressing S1-N fusion protein

Additional COVID-19 vaccines that are safe and immunogenic are needed for global vaccine equity. Here, we developed a recombinant type 5 adenovirus vector encoding for the SARS-CoV-2 S1 subunit antigen and nucleocapsid as a fusion protein (Ad5.SARS-CoV-2-S1N). A single subcutaneous immunization with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khan, Muhammad S, Kim, Eun, McPherson, Alex, Weisel, Florian J, Huang, Shaohua, Kenniston, Thomas W, Percivalle, Elena, Cassaniti, Irene, Baldanti, Fausto, Meisel, Marlies, Gambotto, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372896/ https://www.ncbi.nlm.nih.gov/pubmed/35967905 http://dx.doi.org/10.1093/abt/tbac015

Ejemplares similares

SARS-CoV-2 S1 Subunit Booster Vaccination Elicits Robust Humoral Immune Responses in Aged Mice
por: Kim, Eun, et al.
Publicado: (2023)

A single subcutaneous or intranasal immunization with adenovirus‐based SARS‐CoV‐2 vaccine induces robust humoral and cellular immune responses in mice
por: Kim, Eun, et al.
Publicado: (2021)

Tetravalent SARS-CoV-2 S1 Subunit Protein Vaccination Elicits Robust Humoral and Cellular Immune Responses in SIV-Infected Rhesus Macaque Controllers
por: Khan, Muhammad S., et al.
Publicado: (2023)

Tetravalent SARS-CoV-2 S1 subunit protein vaccination elicits robust humoral and cellular immune responses in SIV-infected rhesus macaque controllers
por: Khan, Muhammad S., et al.
Publicado: (2023)

Trivalent SARS-CoV-2 S1 Subunit Protein Vaccination Induces Broad Humoral Responses in BALB/c Mice
por: Khan, Muhammad S., et al.
Publicado: (2023)

Thirteen Years of Phleboviruses Circulation in Lombardy, a Northern Italy Region
por: Percivalle, Elena, et al.
Publicado: (2021)

Authors’ response: COVID-19: how accurate are seroprevalence studies?
por: Cassaniti, Irene, et al.
Publicado: (2020)

Preventative Vaccines for Zika Virus Outbreak: Preliminary Evaluation
por: Kim, Eun, et al.
Publicado: (2016)

West Nile or Usutu Virus? A Three-Year Follow-Up of Humoral and Cellular Response in a Group of Asymptomatic Blood Donors
por: Percivalle, Elena, et al.
Publicado: (2020)

Evaluation of the Neutralizing Antibodies Response against 14 SARS-CoV-2 Variants in BNT162b2 Vaccinated Naïve and COVID-19 Positive Healthcare Workers from a Northern Italian Hospital
por: Sammartino, Josè Camilla, et al.
Publicado: (2022)

Both SARS-CoV-2 infection and vaccination in pregnancy elicited neutralizing antibodies in pregnant women and newborns
por: Cassaniti, Irene, et al.
Publicado: (2021)

Differential Kinetics of Effector and Memory Responses Induced by Three Doses of SARS-CoV-2 mRNA Vaccine in a Cohort of Healthcare Workers
por: Bergami, Federica, et al.
Publicado: (2022)

Zika Virus Infection in Pregnancy: Advanced Diagnostic Approaches in Dengue-Naive and Dengue-Experienced Pregnant Women and Possible Implication for Cross-Reactivity and Cross-Protection
por: Zavattoni, Maurizio, et al.
Publicado: (2019)

SARS-CoV-2 positivity in rectal swabs: implication for possible transmission
por: Novazzi, Federica, et al.
Publicado: (2020)

SARS-CoV-2 variants inactivation of plasma units using a riboflavin and ultraviolet light-based photochemical treatment
por: Ferrari, Alessandro, et al.
Publicado: (2022)

Persistence of Immune Response Elicited by Three Doses of mRNA Vaccine against SARS-CoV-2 in a Cohort of Patients with Solid Tumors: A One-Year Follow-Up
por: Lasagna, Angioletta, et al.
Publicado: (2023)

Human mesenchymal stromal cells do not express ACE2 and TMPRSS2 and are not permissive to SARS‐CoV‐2 infection
por: Avanzini, Maria A., et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 in blood donors from the Lodi Red Zone and adjacent Lodi metropolitan and suburban area
por: Cassaniti, Irene, et al.
Publicado: (2021)

Macrophages and Monocytes: “Trojan Horses” in COVID-19
por: Percivalle, Elena, et al.
Publicado: (2021)

Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020
por: Percivalle, Elena, et al.
Publicado: (2020)

Effect of a Third Dose of SARS-CoV-2 mRNA BNT162b2 Vaccine on Humoral and Cellular Responses and Serum Anti-HLA Antibodies in Kidney Transplant Recipients
por: Cassaniti, Irene, et al.
Publicado: (2022)

Incidence of SARS-CoV-2 infection in health care workers from Northern Italy based on antibody status: immune protection from secondary infection- A retrospective observational case-controlled study
por: Rovida, Francesca, et al.
Publicado: (2021)

Serum and breastmilk SARS-CoV-2 specific antibodies following BNT162b2 vaccine: prolonged protection from SARS-CoV-2 in newborns and older children
por: Ricciardi, Alessandra, et al.
Publicado: (2022)

SARS-CoV-2 Virologic and Immunologic Correlates in Patients with Olfactory and Taste Disorders
por: Benazzo, Marco, et al.
Publicado: (2020)

Molecular Epidemiology of Rhinovirus/Enterovirus and Their Role on Cause Severe and Prolonged Infection in Hospitalized Patients
por: Giardina, Federica A. M., et al.
Publicado: (2022)

Immunological Aspects of Human Papilloma Virus-Related Cancers Always Says, “I Am like a Box of Complexity, You Never Know What You Are Gonna Get”
por: Soleymaninejadian, Ehsan, et al.
Publicado: (2022)

SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay
por: Cassaniti, Irene, et al.
Publicado: (2021)

Cytokine Responses to Adenovirus and Adenovirus Vectors
por: Atasheva, Svetlana, et al.
Publicado: (2022)

Characterization of Varicella-Zoster (VZV) Specific T Cell Response in Healthy Subjects and Transplanted Patients by Using Enzyme Linked Immunospot (ELISpot) Assays
por: Cassaniti, Irene, et al.
Publicado: (2021)

Adenoviruses as vaccine vectors
por: Tatsis, Nia, et al.
Publicado: (2004)

Swine Influenza A(H3N2) Virus Infection in Immunocompromised Man, Italy, 2014
por: Piralla, Antonio, et al.
Publicado: (2015)

Immune Response to BNT162b2 in Solid Organ Transplant Recipients: Negative Impact of Mycophenolate and High Responsiveness of SARS-CoV-2 Recovered Subjects against Delta Variant
por: Cassaniti, Irene, et al.
Publicado: (2021)

Evaluation of EBV- and HCMV-Specific T Cell Responses in Systemic Lupus Erythematosus (SLE) Patients Using a Normalized Enzyme-Linked Immunospot (ELISPOT) Assay
por: Cassaniti, Irene, et al.
Publicado: (2019)

Severe acute respiratory syndrome coronavirus 2 RNA contamination of inanimate surfaces and virus viability in a health care emergency unit
por: Colaneri, M., et al.
Publicado: (2020)

A Candidate H1N1 Pandemic Influenza Vaccine Elicits Protective Immunity in Mice
por: Steitz, Julia, et al.
Publicado: (2010)

SARS-CoV-2 viability on different surfaces after gaseous ozone treatment: a preliminary evaluation
por: Percivalle, E., et al.
Publicado: (2021)

Effectiveness of the available early therapies in reducing severe COVID-19 in non-hospitalized patients with solid tumors on active treatment
por: Lasagna, Angioletta, et al.
Publicado: (2022)

Genetic and Chemical Capsid Modifications of Adenovirus Vectors to Modulate Vector–Host Interactions
por: Weklak, Denice, et al.
Publicado: (2021)

Simian adenoviruses as vaccine vectors
por: Morris, Susan J, et al.
Publicado: (2016)

Genetic divergence of influenza A NS1 gene in pandemic 2009 H1N1 isolates with respect to H1N1 and H3N2 isolates from previous seasonal epidemics
por: Campanini, Giulia, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_7cmqv2q6ep3rovcis5t3ld4sol